Tenax Therapeutics
TENX
19 hedge funds and large institutions have $31.4M invested in Tenax Therapeutics in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
4% more capital invested
Capital invested by funds: $30.1M → $31.4M (+$1.29M)
0% more funds holding
Funds holding: 19 → 19 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.42M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.69M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$1.21M |
| 4 |
Axa
Paris,
France
|
+$121K |
| 5 |
Millennium Management
New York
|
+$121K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$2.02M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.82M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.57M |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$605K |
| 5 |
BCM
Bluefin Capital Management
New York
|
-$395K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $8K | – | – | – |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $4K | – | – | – |
|
|
KCM
28
Karp Capital Management
Sausalito,
California
| $3K | – | – | – |
|
29
Bank of Montreal
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
PRCM
31
Pine River Capital Management
Minnetonka,
Minnesota
| – | -$2.02M | -16 | Closed |
|
|
32
Bank of America
Charlotte,
North Carolina
| – | -$1.57M | -13 | Closed |
|
|
33
Group One Trading
Chicago,
Illinois
| – | -$605K | -5 | Closed |
|
|
BCM
34
Bluefin Capital Management
New York
| – | -$395K | -3 | Closed |
|
35
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$2K | – | – |
|
36
SG Americas Securities
New York
| – | -$55K | – | – |
|
TENX Hedge Fund Activity: Q4 2014 in Review
19 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2014, worth a combined $31.4M — up 4.3% from $30.1M a quarter earlier.
Fund positioning in TENX was balanced in Q4 2014: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.42M. The largest seller was Pine River Capital Management, exiting entirely with an estimated $2.02M sold.
- 19 institutional investors held Tenax Therapeutics (TENX) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $31.4M of Tenax Therapeutics stock for Q4 2014, up 4.3% quarter-over-quarter.
- 4 funds opened new Tenax Therapeutics positions in Q4 2014 and 4 closed out, a net change of 0 holders.
- The largest Tenax Therapeutics buyer in Q4 2014 was Vanguard Group, an estimated $2.42M added.
- The largest Tenax Therapeutics seller in Q4 2014 was Pine River Capital Management, an estimated $2.02M sold.
Based on aggregated 13F filings for Q4 2014.